{"id":"https://openalex.org/W2017778437","doi":"https://doi.org/10.5414/cp201556","title":"Influence of renal impairment on the pharmacokinetics of oral roflumilast: an open-label, parallel-group, single-center study","display_name":"Influence of renal impairment on the pharmacokinetics of oral roflumilast: an open-label, parallel-group, single-center study","publication_year":2011,"publication_date":"2011-07-25","ids":{"openalex":"https://openalex.org/W2017778437","doi":"https://doi.org/10.5414/cp201556","mag":"2017778437","pmid":"https://pubmed.ncbi.nlm.nih.gov/21781649"},"language":"en","primary_location":{"id":"doi:10.5414/cp201556","doi":"https://doi.org/10.5414/cp201556","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp201556","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111782002","display_name":"T.D. Bethke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.D. Bethke","raw_affiliation_strings":["Nycomed GmbH, Konstanz, Germany. thomas.bethke@nycomed.com","Nycomed GmbH, Konstanz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nycomed GmbH, Konstanz, Germany. thomas.bethke@nycomed.com","institution_ids":[]},{"raw_affiliation_string":"Nycomed GmbH, Konstanz, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Hartmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Hartmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065980128","display_name":"Andreas H\u00fcnnemeyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. H\u00fcnnemeyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108722032","display_name":"Gez Lahu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I221273032","display_name":"Altana (Netherlands)","ror":"https://ror.org/05tgveb11","country_code":"NL","type":"company","lineage":["https://openalex.org/I221273032","https://openalex.org/I4210102110"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"G. Lahu","raw_affiliation_strings":["Altana (Netherlands), Deventer, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altana (Netherlands), Deventer, Netherlands","institution_ids":["https://openalex.org/I221273032"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111894680","display_name":"Christoph H. Gleiter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.H. Gleiter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3909,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.85719162,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"49","issue":"08","first_page":"491","last_page":"499"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6689000129699707,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6689000129699707,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.19269999861717224,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.032099999487400055,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/roflumilast","display_name":"roflumilast","score":0.9990000128746033},{"id":"https://openalex.org/keywords/roflumilast-n-oxide","display_name":"roflumilast N-oxide","score":0.9660000205039978},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8560000061988831},{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/severe-copd","display_name":"severe COPD","score":0.7929999828338623},{"id":"https://openalex.org/keywords/glucuronide-metabolites","display_name":"glucuronide metabolites","score":0.8220000267028809},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.703000009059906},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C2778926808","wikidata":"https://www.wikidata.org/wiki/Q693482","display_name":"Roflumilast","level":3,"score":0.9312648773193359},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.84199059009552},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.798058032989502},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7095478773117065},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5525937080383301},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.513580322265625},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.47970837354660034},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4469645023345947},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.417070209980011},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.41053956747055054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4024645984172821},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.39944782853126526},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3349802494049072},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.13999855518341064}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.5414/cp201556","doi":"https://doi.org/10.5414/cp201556","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp201556","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:21781649","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21781649","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Controlled Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048057663","https://openalex.org/W4310938189","https://openalex.org/W2423755878","https://openalex.org/W2014579471","https://openalex.org/W2161595437","https://openalex.org/W2098761057","https://openalex.org/W2903173077","https://openalex.org/W4297956686","https://openalex.org/W2119158601","https://openalex.org/W2064238287"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Roflumilast":[1,23],"is":[2,216],"a":[3,146,208],"novel,":[4],"orally":[5],"active,":[6],"selective":[7],"phosphodiesterase":[8],"4":[9],"inhibitor":[10],"recently":[11],"approved":[12],"in":[13,149,168,179,192,210,219],"the":[14,18,35,46,131,211],"European":[15],"Union":[16],"for":[17],"treatment":[19],"of":[20,30,42,48,113,127,153,198,214],"severe":[21,67],"COPD.":[22],"and":[24,50,80,85,111,115,145,159,181],"its":[25,51],"metabolites":[26],"are":[27,197],"mainly":[28],"(70%":[29],"total":[31],"radioactivity)":[32],"eliminated":[33],"via":[34],"kidneys":[36],"as":[37],"glucuronides.":[38],"The":[39,188],"potential":[40],"impact":[41],"renal":[43,68,195,222],"impairment":[44,69,196],"on":[45],"pharmacokinetics":[47,110],"roflumilast":[49,55,114,116,154,160,215],"active":[52],"main":[53],"metabolite":[54],"N-oxide":[56,117,161],"were":[57,98,118,166,183],"characterized.":[58],"MATERIALS":[59],"AND":[60],"METHODS:":[61],"Patients":[62],"(n":[63,90],"=":[64,91],"12)":[65],"with":[66,173,194,221],"(creatinine":[70],"clearance":[71],"CL(CR)":[72,93],"<":[73],"30":[74],"ml/":[75],"min/1.73":[76],"m\u00b2;":[77],"otherwise":[78],"healthy)":[79],"matched":[81],"(sex,":[82],"age,":[83],"weight,":[84],"height)":[86],"healthy":[87,174],"control":[88],"subjects":[89],"12;":[92],">":[94],"80":[95],"ml/min/1.73":[96],"m\u00b2)":[97],"enrolled":[99],"into":[100],"an":[101],"open-label,":[102],"parallelgroup":[103],"study.":[104],"Single":[105],"dose":[106,205],"(500":[107],"\u03bcg,":[108],"p.o.)":[109],"safety/tolerability":[112],"compared":[119,172],"between":[120,185],"both":[121],"groups.":[122,186],"RESULTS:":[123],"A":[124,204],"minor":[125],"decrease":[126],"exposure":[128],"(area":[129],"under":[130],"plasma":[132,142],"concentration-time":[133],"curve":[134],"from":[135],"time":[136],"zero":[137],"to":[138],"infinity":[139],"(AUC(0-\u221e)),":[140],"maximum":[141],"concentration":[143],"(C(max)))":[144],"small":[147,199],"increase":[148],"elimination":[150],"half-life":[151],"(t(1/2))":[152],"(-1%;":[155],"-6%;":[156],"+19%,":[157],"respectively)":[158,165],"(-%;":[162],"ND;":[163],"+30%,":[164],"observed":[167,184,191],"renally":[169],"impaired":[170],"patients":[171,193,220],"subjects.":[175],"No":[176],"relevant":[177],"differences":[178],"safety":[180],"tolerability":[182],"CONCLUSIONS:":[187],"pharmacokinetic":[189],"changes":[190],"magnitude":[200],"without":[201],"clinical":[202],"importance.":[203],"adjustment":[206],"or":[207],"change":[209],"administration":[212],"interval":[213],"not":[217],"necessary":[218],"impairment.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}